<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><condition>Colorectal Cancer</condition><disease>Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/85063</full_dataset_link><location>China</location><study_start_month>2</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Effects of general anesthesia with remimazolam on immune function and quality of postoperative recovery in patients undergoing radical colorectal cancer surgery</name><description>Interventions: Group R:Remimazolam for induction and maintenance of anesthesia;Group P:Propofol for induction and maintenance of anesthesia
Primary outcome(s): Immune function
Study Design: Parallel</description><dates><creation>2023-02-15</creation></dates><accession>85063</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2300068931</Chinese Clinical Trial Register></cross_references></HashMap>